Loss of reactivity of a BALB/c myeloma t
โ
J. H. Russel; A. H. Hale; D. Inbar; H. N. Eisen
๐
Article
๐
1978
๐
John Wiley and Sons
๐
English
โ 674 KB
## Abstract It was previously observed that MOPCโ315EL, a subline of the BALB/c myeloma tumor MOPCโ315, varies in its ability to interact with primary antiโHโ2^d^ cytotoxic thymusโderived lymphocytes (CTL) while remaining invariant in its expression of cell surface antigens recognized by antiโHโ2^d